220 related articles for article (PubMed ID: 12577148)
1. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study.
Blot S; Vandewoude K; Colardyn F
Intensive Care Med; 2003 Mar; 29(3):471-5. PubMed ID: 12577148
[TBL] [Abstract][Full Text] [Related]
2. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia.
Blot S; Vandewoude K; Hoste E; De Waele J; Kint K; Rosiers F; Vogelaers D; Colardyn F
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):912-5. PubMed ID: 14700406
[TBL] [Abstract][Full Text] [Related]
3. Multidrug Resistance Acinetobacter Bacteremia Secondary to Ventilator-Associated Pneumonia: Risk Factors and Outcome.
Brotfain E; Borer A; Koyfman L; Saidel-Odes L; Frenkel A; Gruenbaum SE; Rosenzweig V; Zlotnik A; Klein M
J Intensive Care Med; 2017 Oct; 32(9):528-534. PubMed ID: 26902255
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study.
García-Garmendia JL; Ortiz-Leyba C; Garnacho-Montero J; Jiménez-Jiménez FJ; Pérez-Paredes C; Barrero-Almodóvar AE; Gili-Miner M
Clin Infect Dis; 2001 Oct; 33(7):939-46. PubMed ID: 11528563
[TBL] [Abstract][Full Text] [Related]
5. Acinetobacter baumannii: a threat for the ICU?
Rello J; Diaz E
Intensive Care Med; 2003 Mar; 29(3):350-1. PubMed ID: 12589534
[No Abstract] [Full Text] [Related]
6. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
[TBL] [Abstract][Full Text] [Related]
7. Attributable mortality of nosocomial Acinetobacter bacteremia.
Grupper M; Sprecher H; Mashiach T; Finkelstein R
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):293-8. PubMed ID: 17326019
[TBL] [Abstract][Full Text] [Related]
8. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients.
Blot S; De Bacquer D; Hoste E; Depuydt P; Vandewoude K; De Waele J; Benoit D; De Schuijmer J; Colardyn F; Vogelaers D
Infect Control Hosp Epidemiol; 2005 Apr; 26(4):352-6. PubMed ID: 15865270
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study.
Garnacho J; Sole-Violan J; Sa-Borges M; Diaz E; Rello J
Crit Care Med; 2003 Oct; 31(10):2478-82. PubMed ID: 14530754
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients.
Wisplinghoff H; Perbix W; Seifert H
Clin Infect Dis; 1999 Jan; 28(1):59-66. PubMed ID: 10028073
[TBL] [Abstract][Full Text] [Related]
12. [Infections caused by Acinetobacter spp. in critically ill ICU patients].
Alvarez-Lerma F; Palomar M; Insausti J; Olaechea P; Cerdá E; Castillo F; Martínez-Pellús A;
Enferm Infecc Microbiol Clin; 2005 Nov; 23(9):533-9. PubMed ID: 16324565
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of outcome in critically ill patients with nosocomial enterobacter bacteremia: results of a matched cohort study.
Blot SI; Vandewoude KH; Colardyn FA
Chest; 2003 Apr; 123(4):1208-13. PubMed ID: 12684313
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Anunnatsiri S; Tonsawan P
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients.
Blot SI; Vandewoude KH; Colardyn FA
Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):471-3. PubMed ID: 12111606
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
17. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.
Leão AC; Menezes PR; Oliveira MS; Levin AS
BMC Infect Dis; 2016 Aug; 16():386. PubMed ID: 27506948
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
Pradhan NP; Bhat SM; Ghadage DP
J Assoc Physicians India; 2014 Oct; 62(10):18-21. PubMed ID: 25906516
[TBL] [Abstract][Full Text] [Related]
19. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
[TBL] [Abstract][Full Text] [Related]
20. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
